| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| MetaVia Inc. | Gemcabene - COBALT-1 | Homozygous Familial Hypercholesterolemia (HoFH) | Phase 2b | Trial Discontinued | Oral | Cardiology |
| MetaVia Inc. | Gemcabene | Dyslipidemia | Phase 2 | Trial Discontinued | Oral | Cardiology |
| MetaVia Inc. | Vanoglipel (DA-1241) | Metabolic dysfunction-associated steatohepatitis (MASH) | Phase 2a | Data Released | Oral | Gastroenterology |
| Milestone Pharmaceuticals Inc. | Etripamil - (NODE-303) | Paroxysmal supraventricular tachycardia (PSVT) | Phase 3 | Data Released | Intranasal | Cardiology |
| Milestone Pharmaceuticals Inc. | Etripamil - (NODE-301) | Paroxysmal supraventricular tachycardia (PSVT) | Phase 3 | Data Released | Intranasal | Cardiology |
| Milestone Pharmaceuticals Inc. | Etripamil - NODE-302 | Paroxysmal supraventricular tachycardia (PSVT) | Phase 3 | Trial Completed | Intranasal | Cardiology |
| Milestone Pharmaceuticals Inc. | Etripamil (ReVeRA) | Atrial fibrillation | Phase 2/3 | Trial Planned | Intranasal | Cardiology |
| MiMedx Group Inc | mdHACM - (KOA) | Knee Osteoarthritis | Phase 2b | Trial Discontinued | Intra-articular | Orthopedic |